A Cell Press partner journal
See the unseen. Change the unchanged.
The Innovation í¬ published by Cell Press in partnership with members of the Youth
Innovation Promotion Association (YIPA),a part of the Chinese Academy of
Sciencesí¬is a new broad-scope, open access journal publishing basic and applied
research that has impact for the benefit of society.
On the cover: On the cover: Nourished by the gigantic data and empowered by increasing computing facilities, Artificial Intelligence (AI) is setting us free from many burdensome routines. With AI muscles, we have become faster and smarter than ever. AI is reshaping the future of industries and our lives, enabling paradigm shifts in many disciplines of science and even paving the road to the metaverse. But scientists are still facing endless choices to navigate their innovation processes as previously. Meanwhile, collaborations are urgently needed amongst researchers from multidisciplinary studies. So we do hope the shared values of truth, righteousness, and peace can be cherished deeply to make our blue planet a better place for the whole ecosystem.
  Related comments
Add comment (English only)
Name*:  
E-mail:  
Telephone:  
Code:    
Comments*:
Position: Home > issue > November 28, 2021 Volume 2, Issue 4
Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?
Category:   Commentary   Download:  PDF  Figure  Endnote
Author: Lei Zhao,Wu Zhong

22.jpg

Mechanism of action of favipiravir against SARS-CoV-2

Favipiravir is a novel broad-spectrum antiviral drug against RNA viruses that has been approved for the treatment of seasonal and pandemic influenza. The use of favipiravir is a potential therapeutic approach to SARS-CoV-2 infection; several clinical trials have shown that favipiravir could effectively improve the clinical recovery and/or viral RNA clearance of patients, with proven safety profiles.1,2 Favipiravir is a prodrug and its active form, favipiravir ribofuranosyl-triphosphate (FTP), inhibits viral replication by targeting the RNA-dependent RNA polymerase (RdRp).


DOI:
https://doi.org/10.1016/j.xinn.2021.100165

Citation:
Zhao L., Zhong W. (2021). Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination? The Innovation. 2(4),100165.





Host
Publishing partner
Journal links
Academic co-partner
  SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS
  INSTITUTE OF MICROBIOLOGY, CAS
  XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
Stay connected

  office@the-innovation.org
  the.innovation.journal
  the.innovation.journal
  The_InnovationJ
  TheInnovation┤┤đ┬
  TheInnovation┤┤đ┬
  The Innovation
  The_Innovation

  Copyright © 2019-2021 Youth Innovation All Rights Reserved